Package Leaflet: Information for the User
FENOFIBRATE SUN 200 mg HARD CAPSULES EFG
Fenofibrate
Read the entire package leaflet carefully before starting to take this medication, as it contains important information for you.
Contents of the Package Leaflet
This medication belongs to a group of medications commonly known as fibrates. These medications are used to reduce the level of fats (lipids) in the blood. For example, fats called triglycerides.
Fenofibrate is used, along with a low-fat diet and other non-medical treatments such as exercise and weight loss, to reduce fat levels in the blood.
This medication may be used in combination with other medications (statins) in certain circumstances when a statin alone does not control blood fat levels.
Do not take Fenofibrate SUN
Consult your doctor or pharmacist before starting to take this medication.
Effects on your muscles
Stop taking Fenofibrate 200 mg and go to your doctor immediately if you experience
This is because this medication can cause muscle problems that can be serious.
These problems occur rarely but include muscle inflammation and destruction. This can cause kidney damage or even death.
Your doctor may perform blood tests to check your muscles before and after starting treatment.
The risk of muscle destruction is higher in certain patients. Consult your doctor if:
If you are taking medications called statins to lower cholesterol, such as simvastatin, atorvastatin, pravastatin, rosuvastatin, or fluvastatin.
Use of Fenofibrate SUN with other medications
Tell your doctor or pharmacist if you are taking, have recently taken, or may need to take any other medication.
In particular, inform your doctor or pharmacist if you are taking any of the following medications:
If any of the above cases apply to you (or if you are unsure), consult your doctor or pharmacist before taking Fenofibrate 200 mg.
Taking Fenofibrate SUN with food and drinks
It is essential to take the capsule with food. This medication will not work as well if your stomach is empty.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
Since there is not enough evidence on the use of fenofibrate during pregnancy, you should only use Fenofibrate SUN if your doctor considers it absolutely necessary.
It is not known if fenofibrate passes into breast milk. Therefore, you should not use Fenofibrate SUN if you are breastfeeding or plan to breastfeed your baby.
Consult your doctor or pharmacist before taking any medication.
This medication has not been observed to affect the ability to drive and use machines.
Fenofibrate SUN contains lactose and orange-yellow colorant (E-110):
This medication contains lactose. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
This medication may cause allergic reactions because it contains orange-yellow colorant (E-110). It can cause asthma, especially in patients allergic to acetylsalicylic acid.
This medication contains less than 23 mg of sodium (1 mmol) per capsule; it is essentially "sodium-free".
Follow your doctor's instructions for taking this medication exactly. If you are unsure, consult your doctor or pharmacist again.
The recommended dose for adults is one capsule (200 mg of fenofibrate) per day during one of the main meals, in combination with a suitable diet.
If you are currently taking a 145 mg or 160 mg tablet, you can switch to a 200 mg fenofibrate capsule without needing to adjust the dose.
For proper use of this medication, regular medical monitoring is essential.
Taking the medication
People with kidney problems
If you have kidney problems, your doctor may recommend taking a lower dose. Ask your doctor or pharmacist.
People with liver problems
Fenofibrate SUN is not recommended for patients with liver failure due to the lack of data.
Use in children and adolescents
The safety and efficacy of fenofibrate in children and adolescents under 18 years of age have not been established. There are no available data. Therefore, the use of fenofibrate is not recommended in children and adolescents under 18 years of age.
If you think the effect of Fenofibrate SUN is too strong or too weak, tell your doctor or pharmacist.
In case of overdose, accidental ingestion, or if you suspect that a child has swallowed several whole capsules, consult your doctor as soon as possible or call the Toxicology Information Service at 91 562 04 20, indicating the medication and the amount taken. It is recommended to bring the package and the package leaflet of the medication to the healthcare professional.
Do not worry if you have forgotten to take a dose (capsule) of 200 mg. Take a dose with your next meal and then continue with your treatment as usual.
Do not take a double dose to make up for forgotten doses. If you have any doubts, consult your doctor or pharmacist.
If you stop taking Fenofibrate SUN
Do not stop taking Fenofibrate SUN 200 mg unless your doctor tells you to or if the capsules make you feel unwell. This is because abnormal blood fat levels need to be treated for a long time.
Remember that taking Fenofibrate SUN is important, as well as having a low-fat diet and exercising regularly.
If you have any other questions about the use of this medication, ask your doctor, pharmacist, or nurse.
Like all medications, this medication can have side effects, although not everyone gets them.
Stop taking Fenofibrate SUN and go to your doctor immediately if you notice any of the following serious side effects, as you may need urgent medical attention:
Uncommon:may affect up to 1 in 100 people
Rare:may affect up to 1 in 1,000 people
Frequency not known:cannot be estimated from the available data
If you experience any of the above effects, consult your doctor immediately and stop taking Fenofibrate 200 mg.
Other side effects are:
Common(may affect up to 1 in 10 patients):
Uncommon(may affect up to 1 in 100 patients):
Rare(may affect up to 1 in 1,000 patients):
Frequency not known (cannot be estimated from the available data):
If you experience any side effect, tell your doctor, pharmacist, or nurse, even if it is not listed in this package leaflet.
Reporting side effects:
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect not listed in this package leaflet. You can also report them directly through the Spanish Medicines Monitoring System: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date stated on the package.
Medications should not be disposed of via wastewater or household waste. Deposit the packages and medications you no longer need at the SIGRE collection point in your pharmacy. If you have any doubts, ask your pharmacist how to dispose of packages and medications you no longer need. This will help protect the environment.
Composition of Fenofibrate SUN
The active ingredient is fenofibrate.
The other ingredients are: lactose monohydrate, sodium lauryl sulfate, pregelatinized cornstarch, crospovidone, talc, anhydrous colloidal silica, magnesium stearate.
The ingredients of the capsule are: gelatin, orange-yellow colorant (E-110), and titanium dioxide (E-171).
The ingredients of the printing ink are: shellac, black iron oxide (E-172), n-butyl alcohol, propylene glycol, ammonia hydroxide, dehydrated ethanol, isopropyl alcohol, and purified water.
Appearance of the product and package contents
The capsules are orange in color, size "0", marked with "FB 200", containing white powder inside.
The capsules are packaged in thermoformed blister packs (PVC/PVdC-Alu).
This medication is available in packages of 30 capsules.
Marketing Authorization Holder
Sun Pharmaceutical Industries Europe B.V.
Polarisavenue 87
2132JH Hoofddorp
Netherlands
Manufacturer
Sun Pharmaceutical Industries Europe B.V.
Polarisavenue 87
2132JH Hoofddorp
Netherlands
Alkaloida Chemical Company Zrt.
Kabay Janós u. 29.,
Tiszavasvári - 4440
Hungary
Local Representative
Sun Pharma Laboratorios, S.L.
Rambla de Catalunya 53-55
08007 Barcelona
Spain
Date of the last revision of this package leaflet: May 2019
Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The average price of FENOFIBRATE SUN 200 mg HARD CAPSULES in October, 2025 is around 5.46 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.